JP2024518844A5 - - Google Patents
Info
- Publication number
- JP2024518844A5 JP2024518844A5 JP2023571586A JP2023571586A JP2024518844A5 JP 2024518844 A5 JP2024518844 A5 JP 2024518844A5 JP 2023571586 A JP2023571586 A JP 2023571586A JP 2023571586 A JP2023571586 A JP 2023571586A JP 2024518844 A5 JP2024518844 A5 JP 2024518844A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163201952P | 2021-05-20 | 2021-05-20 | |
| US63/201,952 | 2021-05-20 | ||
| PCT/US2022/030189 WO2022246154A2 (en) | 2021-05-20 | 2022-05-20 | Antibodies that bind to c1s and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518844A JP2024518844A (ja) | 2024-05-07 |
| JP2024518844A5 true JP2024518844A5 (enExample) | 2025-05-28 |
Family
ID=84141843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571586A Pending JP2024518844A (ja) | 2021-05-20 | 2022-05-20 | Ｃ１ｓに結合する抗体およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12252550B2 (enExample) |
| EP (1) | EP4340879A4 (enExample) |
| JP (1) | JP2024518844A (enExample) |
| CN (1) | CN117769434A (enExample) |
| WO (1) | WO2022246154A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023385709A1 (en) | 2022-11-21 | 2025-06-12 | Dianthus Therapeutics Opco, Inc. | Antibodies that bind to c1s and uses thereof |
| JP2026510831A (ja) | 2023-03-16 | 2026-04-10 | ジェンザイム・コーポレーション | 萎縮型加齢黄斑変性の治療 |
| US20250206814A1 (en) * | 2023-12-20 | 2025-06-26 | Dianthus Therapeutics Opco, Inc. | Pharmaceutical compositions comprising antibodies for treatment of c1s mediated disorders and methods of using the same |
| WO2025129535A1 (en) * | 2023-12-20 | 2025-06-26 | Dianthus Therapeutics Opco, Inc. | Pharmaceutical compositions comprising antibodies for treatment of c1s mediated disorders and methods of using the same |
| TW202547886A (zh) * | 2024-02-02 | 2025-12-16 | 美商黛安瑟斯醫療運營公司 | 用於治療ｃ１ｓ介導的疾病和病症的組成物、劑量和方法 |
| WO2025255340A2 (en) | 2024-06-05 | 2025-12-11 | Genzyme Corporation | BINDING PROTEINS THAT TARGET aC1s, TfR, OR BOTH, AND COMPOSITIONS THEREOF |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| WO1988001649A1 (en) | 1986-09-02 | 1988-03-10 | Genex Corporation | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| DE69233528T2 (de) | 1991-11-25 | 2006-03-16 | Enzon, Inc. | Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| PT1621554E (pt) | 1992-08-21 | 2009-07-13 | Univ Bruxelles | Imunoglobtainas desprovidas de cadeias leves |
| US6005079A (en) | 1992-08-21 | 1999-12-21 | Vrije Universiteit Brussels | Immunoglobulins devoid of light chains |
| US6838254B1 (en) | 1993-04-29 | 2005-01-04 | Conopco, Inc. | Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae |
| GB9818110D0 (en) | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6096002A (en) | 1998-11-18 | 2000-08-01 | Bioject, Inc. | NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method |
| JP4336498B2 (ja) | 2000-12-12 | 2009-09-30 | メディミューン，エルエルシー | 延長した半減期を有する分子ならびにその組成物および用途 |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| CA2833917C (en) * | 2011-04-28 | 2020-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Identification of polynucleotides associated with a sample. |
| PL2914291T3 (pl) * | 2012-11-02 | 2022-10-03 | Bioverativ Usa Inc. | Przeciwciała anty-C1s dopełniacza i ich zastosowania |
| WO2014186622A2 (en) | 2013-05-15 | 2014-11-20 | Annexon, Inc. | Methods of treatment for guillain-barre syndrome |
| EP3055328A1 (en) | 2013-10-11 | 2016-08-17 | F. Hoffmann-La Roche AG | Nsp4 inhibitors and methods of use |
| PL3280440T3 (pl) * | 2015-04-06 | 2023-06-19 | Bioverativ Usa Inc. | Humanizowane przeciwciała anty-c1s i sposoby ich zastosowania |
| CN106939047B (zh) | 2016-01-04 | 2021-08-31 | 江苏怀瑜药业有限公司 | 一种pd-l1抗体及其制备方法 |
| EP4652926A3 (en) | 2016-10-12 | 2026-03-18 | Bioverativ USA Inc. | Anti-c1s antibodies and methods of use thereof |
| US11359018B2 (en) | 2016-11-18 | 2022-06-14 | Symphogen A/S | Anti-PD-1 antibodies and compositions |
| BR112019018950A2 (pt) | 2017-03-14 | 2020-04-22 | Bioverativ Usa Inc. | métodos para tratamento de doenças e distúrbios mediados por complemento |
| EP3710589A4 (en) * | 2017-11-14 | 2021-11-10 | Chugai Seiyaku Kabushiki Kaisha | ANTI-C1S ANTIBODIES AND METHOD OF USING |
| WO2022046888A1 (en) | 2020-08-25 | 2022-03-03 | Target Discovery Merger Sub II, LLC | Sars-cov-2 associated antibody compositions and methods of use |
-
2022
- 2022-05-20 EP EP22805547.1A patent/EP4340879A4/en active Pending
- 2022-05-20 US US17/749,362 patent/US12252550B2/en active Active
- 2022-05-20 CN CN202280048661.4A patent/CN117769434A/zh active Pending
- 2022-05-20 WO PCT/US2022/030189 patent/WO2022246154A2/en not_active Ceased
- 2022-05-20 JP JP2023571586A patent/JP2024518844A/ja active Pending
-
2025
- 2025-02-07 US US19/047,877 patent/US20260022195A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7143452B2 (ja) | ＣＤ４７とＳＩＲＰａの相互作用を遮断できる抗体及びその応用 | |
| TWI757304B (zh) | Lag-3抗體、其抗原結合片段及其醫藥用途 | |
| TWI821474B (zh) | Ｃｄ３抗體及其藥物用途 | |
| CN115397852B (zh) | 工程化抗il-2抗体 | |
| KR20230113348A (ko) | 항 ＳＩＲＰα 항체 및 이의 용도 | |
| US20220031842A1 (en) | Lag-3 antibody pharmaceutical composition and use thereof | |
| CN116490210A (zh) | Cd70抗体及其应用 | |
| TWI788698B (zh) | 抗ｐｄ-ｌ１抗體及其應用 | |
| CN112969476A (zh) | 多特异性蛋白分子 | |
| JP2020515277A5 (enExample) | ||
| JP2024024114A5 (enExample) | ||
| TWI869542B (zh) | 抗ＦｃＲｎ抗體、其抗原結合片段及其醫藥用途 | |
| WO2022242703A1 (zh) | 抗msln抗体及其应用 | |
| WO2022218380A1 (zh) | 靶向bcma的多特异性抗体 | |
| WO2023241656A1 (zh) | 包含抗cldn18.2抗体的双特异性抗体、药物组合物及用途 | |
| CN117940460A (zh) | 双特异性抗原结合分子及其应用 | |
| US8974786B2 (en) | Humanized antibodies to CA215 | |
| JP2024505195A5 (enExample) | ||
| CN111100204B (zh) | 靶向cd20的抗体、其制备方法和应用 | |
| WO2022111559A1 (zh) | 双特异性抗体及其用途 | |
| CN120040594B (zh) | 一种靶向flt3基因编辑通用型car-t细胞的制备方法和应用 | |
| CN120383677B (zh) | 靶向gp100/HLA-A2的高特异性TCR-mimic抗体及其制备方法 | |
| WO2024041639A1 (en) | Antibodies targeting tigit and uses thereof | |
| CN115724985A (zh) | 一种cdc平台抗体 | |
| WO2025157244A1 (zh) | 抗b7h3抗体及其应用 |